Phosphorylation of Phospholamban at Threonine-17 Reduces Cardiac Adrenergic Contractile Responsiveness in Chronic Pressure Overload-induced Hypertrophy
Overview
Physiology
Authors
Affiliations
Physiological hemodynamic stress, such as aerobic exercise, is intermittent and requires an increase in Ca2+ -dependent contractility through sympathetic nervous system activation. Pathological hemodynamic stress, such as hypertension, is persistent and requires sustained increases in cardiac function. Over time, this causes left ventricular hypertrophy (LVH)-reduced responsiveness to sympathetic stimulation. In this study, we examined the hypothesis that blunted in vivo adrenergic contractile responsiveness in pressure overload (PO)-induced cardiac hypertrophy is caused by abnormalities in the abundance and/or basal phosphorylation state of Ca2+ regulatory proteins. PO, induced by aortic constriction, caused concentric LVH or dilated LVH. Only animals with dilation exhibited a decrease in baseline left ventricle function [fractional area change (FAC); measured with echocardiography]. All PO animals had a reduced contractile response to adrenergic agonists (increase in FAC with 40 microg.kg(-1).min(-1) dobutamine, control 0.30 +/- 0.04, n = 5 vs. banded 0.10 +/- 0.03, n = 10; P < 0.01). PO animals had reduced phospholamban (PLB) protein abundance (P = 0.07, not significant) and increased PLB phosphorylation at the calmodulin-dependent kinase II (CaMKII)-specific site (PLB-Thr17, P < 0.05) but not at the protein kinase A-specific site (PLB-Ser16). PLB-Thr17 phosphorylation was inversely correlated with dobutamine-induced increases in contractility in PO animals (r2 = 0.81, P < 0.05). Continuous induction of Ca2+ transients in isolated ventricular myocytes for 24 h increased phosphorylation at PLB-Thr17 and diminished inotropic responsiveness and PLB-Ser16 phosphorylation after exposure to isoproterenol (P < 0.05). These data show that reduced adrenergic responsiveness in feline PO hypertrophy and failure involves increases in basal PLB-Thr17 phosphorylation, suggesting that activation of CaMKII in PO hypertrophy contributes to defective adrenergic reserve in compensated LVH and early heart failure.
Abnormal phosphorylation / dephosphorylation and Ca dysfunction in heart failure.
Liu Y, Wang Q, Song Y, Song X, Fan Y, Kong L Heart Fail Rev. 2024; 29(4):751-768.
PMID: 38498262 DOI: 10.1007/s10741-024-10395-w.
Gross P, Johnson J, Romero C, Eaton D, Poulet C, Sanchez-Alonso J Circ Res. 2020; 128(1):92-114.
PMID: 33092464 PMC: 7790862. DOI: 10.1161/CIRCRESAHA.119.315715.
IRAG1 Deficient Mice Develop PKG1β Dependent Pulmonary Hypertension.
Biswas S, Kojonazarov B, Hadzic S, Majer M, Bajraktari G, Novoyatleva T Cells. 2020; 9(10).
PMID: 33066124 PMC: 7601978. DOI: 10.3390/cells9102280.
Tomasi L, Campos D, SantAna P, Okoshi K, Padovani C, Murata G PLoS One. 2018; 13(3):e0193553.
PMID: 29494668 PMC: 5832311. DOI: 10.1371/journal.pone.0193553.
Role of STIM1 (Stromal Interaction Molecule 1) in Hypertrophy-Related Contractile Dysfunction.
Troupes C, Wallner M, Borghetti G, Zhang C, Mohsin S, von Lewinski D Circ Res. 2017; 121(2):125-136.
PMID: 28592415 PMC: 5531450. DOI: 10.1161/CIRCRESAHA.117.311094.